Nemaura Medical has a big winner in its painless SugarBEAT glucose monitor
The medtech company is eyeing explosive growth with SugarBEAT, already launching in the UK, followed by the rest of Europe
Company
Abbott Laboratories
NYSE:ABT
Abbott Laboratories is a global healthcare company. The company’s portfolio of technologies spans the spectrum of healthcare, with businesses and products in diagnostics, medical devices, nutritional and branded generic medicines.
58 stories · page 2 of 3
Ascendiant Capital Markets initiates coverage of Nemaura Medical with Buy rating, $3.25 price target
In addition, Acorn Management analyst Peter Wright says research shows the company's SugarBEAT scores over other glucose monitors on ‘multiple counts’ including affordability and cost
Nemaura Medical rounds out successful human factors usability study for sugarBEAT glucose monitor
This brings the England-based medical technology company a step closer to submitting its medical device application to the FDA for sugarBEAT
Nemaura Medical adds new predictive alert function to its sugarBEAT glucose monitor
CEO Faz Chowdhury says adding the alerts and alarms based on predictive algorithms as part of the current CE review process avoids the need for a subsequent CE application
Nemaura on track for FDA's De Novo submission for sugarBEAT glucose monitor in 2Q
SugarBEAT which has been honed and perfected over seven years is expected to receive CE approval in the UK soon
Nemaura rises after supply deal for its SugarBEAT glucose monitor in Mideast
It’s a strategic move to crack open the wealthy markets of Saudi Arabia, Oman, Kuwait and Bahrain
Nemaura completes clinical studies for De Novo submission to FDA for sugarBEAT glucose monitor
The company plans to apply to the FDA in the first quarter of 2019, which could speed up sugarBEAT’s arrival on American shores
Investments and investor services
Wincanton on the right road as strong cash flow whittles away debt
A look at the day's poppers and droppers, including JD Wetherspoon, Gattaca, Renewi, AdEPT, The Works, Coca-Cola HBC and Micro Focus
Archive
Proactive news snapshot: Immotion Group, NetScientific, AdEPT Technology …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
FTSE 100 closes higher ahead of Federal Reserve meeting
The focus is now on the Federal Reserve meeting later. The interest rate announcement is set for 7.00pm, UK time
Nemaura develops predictive algorithms, alarm functionality for its sugarBEAT glucose monitor
The innovation will make sugarBEAT more appealing and useful to insulin users
Hardware & electrical equipment
Tekcapital's blue-chip hires
The top teams at Tekcapital's investee companies exude quality
OptiBiotix to bring cholesterol reduction product to India with new agreement
The agreement was signed with Akums Drugs and Pharmaceuticals Ltd, a leading contract manufacturer of food and drug supplements in India
Abbott Laboratories posts higher-than-estimated 1Q profit on diagnostics business
Revenue at the medical-products group advanced 17% to US$7.39bln
Archive
Proactive news snapshot Keyword Studios, Directa Plus, Concepta …
A glance at some of the day's highlights from the Proactive Investors newswire
AfriTin Mining gains on MoU with MRI Trading
A look at some of the top risers and fallers in London today
FTSE 100 closes positively as Wall Street rebounds, but Russian stocks hit
The UK blue chip share index finished around 11 points higher at 7,194
Smith & Nephew says former Alere boss, Namal Nawana to join as chief executive from next month
Nawana was most recently chief executive of medical diagnostics company Alere, overseeing its US$5.3bn acquisition by Abbott Laboratories in 2017
Surmodics surges as it inks commercialisation deal with Abbott for SurVeil PAD treatment
Abbott is paying US$25mln upfront plus up to a further US$67mln in milestone payments to Surmodics for the exclusive worldwide commercialisation rights for SurVeil
Archive
Proactive news snapshot: Highlands Natural Resources, ANGLE , Redx Pharma …
A glance at some of the day's highlights from the Proactive Investors newswire